Dextromethorphan hydrochloride

1. A pharmaceutical composition comprising dextromethorphan hydrochloride having the structure:

wherein the dextromethorphan hydrochloride is non-radioactive, wherein the said dextromethorphan hydrochloride is in immediate release form; and wherein the pharmaceutical composition is free or essentially free of bromide.

2. The pharmaceutical composition of claim 1 , wherein the pharmaceutical composition is formulated for oral administration.

3. The pharmaceutical composition of claim 2 , wherein the pharmaceutical composition is a tablet or capsule.

4. The pharmaceutical composition of claim 2 , wherein the pharmaceutical composition is a solution.

5. The pharmaceutical composition of claim 4 , wherein the pharmaceutical composition comprises between 80 mg and 1000 mg dextromethorphan hydrochloride.

6. The pharmaceutical composition of claim 3 , wherein the pharmaceutical composition comprises between 15 mg and 200 mg dextromethorphan hydrochloride.

7. The pharmaceutical composition of claim 2 , wherein the pharmaceutical composition is a good manufacturing grade (GMP) pharmaceutical.

8. A method of treating chronic pain comprising administering the pharmaceutical composition of claim 1 to a subject.

9. The method of claim 8 , wherein the chronic pain results from myofascial pain syndrome, trigger points, tender points, thorasic outlet syndrome, arachnoiditis syndrome, reflex sympathetic dystrophy (RSD), sympathetically maintained pain (SMP), diabetic neuropathy syndrome (DNS); chronic pain associated with fibromyalgia syndrome (FMS), trigeminal neuralgia (TN), multiple sclerosis (MS), a traumatic injury to the peripheral nervous system, an idiopathic or undiagnosed or undiagnosible disease, a chronic disease, herpes zoster (shingles or post-herpetic neuropathy), an infection which results in damage to nerves, post-operative pain, which arises after surgery and then lingers far beyond a normal convalescent period; pain associated with nerve and root damage, an amputation, peripheral neuropathies, tic douloureux, atypical facial pain, arachnoiditis syndrome, a “phantom limb” pain, a carcinoma or cancer pain, a chemotherapy treatment, central nervous system pain, spinal cord or brain stem damage, lower back pain, sciatica, headache, migraine, chronic tension headache, cluster headache, temporomandibular disorder (TMJ) pain or maxillary sinus pain, a complex regional pain syndrome, a reflex sympathetic dystrophy or causalgia, a burn injury, hyperesthesia, allodynia, hyperalgesia, deafferentation pain, sympathetically maintained pain, or non-nociceptive chronic pain.